17 May 2018 Venn Life Sciences Holdings Plc (“Venn”, “Venn Life Sciences” or the “Company”) Preliminary Final Results for the year ended 31 December 2017 Venn Life Sciences (AIM: VENN),… read more →
The current issue of Biotech News & Life Sciences in the Netherlands features an article with our own Johan te Koppele discussing Venn’s end-to-end drug development capabilities in Breda and… read more →
Venn Life Sciences Holdings Plc (“Venn” or the “Company”) Trading and Strategy Update 15 February 2018 Venn Life Sciences (“Venn”) an Integrated Drug Development Partner offering a combination of drug… read more →
Venn Life Sciences Holdings Plc (“Venn” or the “Company”) Acquisition of Minority Interest 23 January 2018 Venn Life Sciences Holdings PLC (“VLS”), today announces that it has reached agreement with… read more →
If you are looking for a role with a dynamic company in Drug Development we are currently looking for candidates in Biostatistics, Finance, Pharmacology, Regulatory & Quality. Click on our… read more →